ALT 0.00% 0.5¢ analytica limited

0.003 next stop, page-8

  1. 134 Posts.
    lightbulb Created with Sketch. 4
    Agree - dead horse IMO now - but SP to low to sell anyway.. Only thing that could save ALT and SP is a really positive clinical trial result however trying to find out when the trial will wrap up and data be released is like trying to get blood from a stone (from management)

    I am starting to suspect management don't release sales figures and clinical trial info to the market as they essentially want to keep themselves in a job for as long as possible..
 
watchlist Created with Sketch. Add ALT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.